Our findings revealed that EZH2, AURKA, BID, PLA2G6, and EPAS1 exhibited significantly elevated expression levels in ccRCC tumor tissues compared to normal tissues. This evidence concerns the gene BID and nonpapillary renal cell carcinoma.